Cargando…

Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study

BACKGROUND: There is a gap between evidence and practice in the management of cardiovascular (CV) risk. Previous research indicated benefits from community-based, multi-faceted interventions to screen, diagnose, and manage CV risk in people with hypertension. METHODS: The Heart Outcomes Prevention a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwalm, Jon-David, McCready, Tara, Lear, Scott A., Lamelas, Pablo, Garis, Len, Musa, Hadi, Vincent, Kaitey, Islam, Shofiqul, Attaran, Amir, McKee, Martin, Yusuf, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984976/
https://www.ncbi.nlm.nih.gov/pubmed/33778443
http://dx.doi.org/10.1016/j.cjco.2020.10.006
_version_ 1783668146109939712
author Schwalm, Jon-David
McCready, Tara
Lear, Scott A.
Lamelas, Pablo
Garis, Len
Musa, Hadi
Vincent, Kaitey
Islam, Shofiqul
Attaran, Amir
McKee, Martin
Yusuf, Salim
author_facet Schwalm, Jon-David
McCready, Tara
Lear, Scott A.
Lamelas, Pablo
Garis, Len
Musa, Hadi
Vincent, Kaitey
Islam, Shofiqul
Attaran, Amir
McKee, Martin
Yusuf, Salim
author_sort Schwalm, Jon-David
collection PubMed
description BACKGROUND: There is a gap between evidence and practice in the management of cardiovascular (CV) risk. Previous research indicated benefits from community-based, multi-faceted interventions to screen, diagnose, and manage CV risk in people with hypertension. METHODS: The Heart Outcomes Prevention and Evaluation 4 Canada pilot study (HOPE 4) was a quasi-experimental pre–post interventional study, involving one community each in Hamilton, Ontario and Surrey, British Columbia, Canada. Individuals aged ≥50 years with newly diagnosed or poorly controlled hypertension were included. The intervention was comprised of: (i) simplified diagnostic/treatment algorithms implemented by community health workers (firefighters in British Columbia and community health workers in Ontario) guided by decision support and counselling software; (ii) recommendations for evidence-based CV medications and lifestyle modifications; and (iii) support from family/friends to promote healthy behaviours. The intervention was developed as part of the international Heart Outcomes Prevention and Evaluation 4 Canada pilot study trial and adapted to the Canadian context. The primary outcome was the change in Framingham Risk Score 10-year CV disease risk estimate between baseline and 6 months. RESULTS: Between 2016 and 2017, a total of 193 participants were screened, with 37 enrolled in Surrey, and 19 in Hamilton. Mean age was 69 years (standard deviation 11), with 54% female, 27% diabetic, and 73% with a history of hypertension. An 82% follow-up level had been obtained at 6 months. Compared to baseline, there were significant improvements in the Framingham Risk Score 10-year risk estimate (30.6% vs 24.7%, P < 0.01), and systolic blood pressure (153.1 vs 136.7 mm Hg, P < 0.01). No significant changes in lipids or healthy behaviours were noted. CONCLUSIONS: A comprehensive approach to health care delivery, using a community-based intervention with community health workers, supported by mobile-health technologies, has the potential to significantly reduce cardiovascular risk, but further evaluation is warranted.
format Online
Article
Text
id pubmed-7984976
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79849762021-03-25 Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study Schwalm, Jon-David McCready, Tara Lear, Scott A. Lamelas, Pablo Garis, Len Musa, Hadi Vincent, Kaitey Islam, Shofiqul Attaran, Amir McKee, Martin Yusuf, Salim CJC Open Original Article BACKGROUND: There is a gap between evidence and practice in the management of cardiovascular (CV) risk. Previous research indicated benefits from community-based, multi-faceted interventions to screen, diagnose, and manage CV risk in people with hypertension. METHODS: The Heart Outcomes Prevention and Evaluation 4 Canada pilot study (HOPE 4) was a quasi-experimental pre–post interventional study, involving one community each in Hamilton, Ontario and Surrey, British Columbia, Canada. Individuals aged ≥50 years with newly diagnosed or poorly controlled hypertension were included. The intervention was comprised of: (i) simplified diagnostic/treatment algorithms implemented by community health workers (firefighters in British Columbia and community health workers in Ontario) guided by decision support and counselling software; (ii) recommendations for evidence-based CV medications and lifestyle modifications; and (iii) support from family/friends to promote healthy behaviours. The intervention was developed as part of the international Heart Outcomes Prevention and Evaluation 4 Canada pilot study trial and adapted to the Canadian context. The primary outcome was the change in Framingham Risk Score 10-year CV disease risk estimate between baseline and 6 months. RESULTS: Between 2016 and 2017, a total of 193 participants were screened, with 37 enrolled in Surrey, and 19 in Hamilton. Mean age was 69 years (standard deviation 11), with 54% female, 27% diabetic, and 73% with a history of hypertension. An 82% follow-up level had been obtained at 6 months. Compared to baseline, there were significant improvements in the Framingham Risk Score 10-year risk estimate (30.6% vs 24.7%, P < 0.01), and systolic blood pressure (153.1 vs 136.7 mm Hg, P < 0.01). No significant changes in lipids or healthy behaviours were noted. CONCLUSIONS: A comprehensive approach to health care delivery, using a community-based intervention with community health workers, supported by mobile-health technologies, has the potential to significantly reduce cardiovascular risk, but further evaluation is warranted. Elsevier 2020-10-13 /pmc/articles/PMC7984976/ /pubmed/33778443 http://dx.doi.org/10.1016/j.cjco.2020.10.006 Text en © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Schwalm, Jon-David
McCready, Tara
Lear, Scott A.
Lamelas, Pablo
Garis, Len
Musa, Hadi
Vincent, Kaitey
Islam, Shofiqul
Attaran, Amir
McKee, Martin
Yusuf, Salim
Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
title Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
title_full Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
title_fullStr Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
title_full_unstemmed Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
title_short Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study
title_sort exploring new models for cardiovascular risk reduction: the heart outcomes prevention and evaluation 4 (hope 4) canada pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984976/
https://www.ncbi.nlm.nih.gov/pubmed/33778443
http://dx.doi.org/10.1016/j.cjco.2020.10.006
work_keys_str_mv AT schwalmjondavid exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT mccreadytara exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT learscotta exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT lamelaspablo exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT garislen exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT musahadi exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT vincentkaitey exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT islamshofiqul exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT attaranamir exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT mckeemartin exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy
AT yusufsalim exploringnewmodelsforcardiovascularriskreductiontheheartoutcomespreventionandevaluation4hope4canadapilotstudy